Company Filing History:
2 out of 290 
2 out of 41 Years Active: 2017
Title: Innovations by Inventor Ying Luo
Introduction
Ying Luo, an accomplished inventor based in Nanchang, China, has made significant contributions to the field of pharmaceutical science. With a total of two patents to his name, he has focused on improving the solubility and stability of pharmaceutical compounds, particularly in relation to agomelatine, a medication used for treating sleep disorders.
Latest Patents
Ying Luo's notable patents include:
1. **Forms of co-crystals of agomelatine and p-toluenesulphonic acid, a process for their preparation, and pharmaceutical compositions containing them** – This patent presents new forms of co-crystals that exhibit improved solubility compared to agomelatine, making them more effective for pharmaceutical applications. The invention emphasizes better stability and purity, while proposing a simple preparation process free from complex steps.
2. **Complexes of agomelatine and sulphonic acids, a process for their preparation, and pharmaceutical compositions containing them** – This innovation highlights the use of agomelatine complexes with sulphonic acids that are beneficial for treating disorders of the melatoninergic system. The resulting medicinal products are crucial for enhancing therapeutic effects.
Career Highlights
Ying Luo has been associated with leading organizations such as Les Laboratoires Servier and the Shanghai Institute of Pharmaceutical Industry. His tenure at these establishments has enabled him to collaborate on various projects, paving the way for groundbreaking developments in the pharmaceutical sector.
Collaborations
Throughout his career, Ying Luo has worked alongside esteemed colleagues, including Hanbin Shan and Yuhui Shen. These collaborations have facilitated valuable research and innovation, contributing to the advancements in pharmaceutical formulations.
Conclusion
Ying Luo continues to be a pivotal figure in the domain of pharmaceutical innovation. His patents reflect a dedication to improving medicinal compositions that address critical health issues. As the pharmaceutical landscape evolves, his contributions are expected to make a lasting impact on treatment options available for patients.